Ezogabine or retigabine
- Level
- Commodity
- Parent
- 51141500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51141561This classification denotes an anticonvulsant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 12G01I6BBU. European Medicines Agency schedules Retigabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10291MIG. Ezogabine generally arises in the molecular formula C16H18FN3O2. The term 'ezogabine' is a European Medicines Agency European Public Assessment Report System designation. Ezogabine or retigabine bears US NLM identifiers UMLS ID C0530684 and NCI Concept Code C72839. SMILES: FC1CCC(CNC2CC(N)C(NC(=O)OCC)CC2)CC1.
Same parent
Under 51141500 · 80Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.